Symbol: CIPLA
Month: 2024-06
Start Price: ₹1440.14
End Price: ₹1468.35
12M Return: 1.96%
6M Return: 1.96%
3M Return: 1.96%
Volatility: 0.204
Sharpe Ratio: 1.431
Max Drawdown: -0.061
Peer Correlation (SUNPHARMA): 0.3623
Peer Correlation (DIVISLAB): 0.4488
Peer Correlation (GRASIM): 0.0152
Average Peer Correlation: 0.2754

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Cipla's stock performance has been relatively stable, with a 1.96% return over the past 12 months, 6 months, and 3 months. The volatility is moderate at 0.204, indicating some price fluctuations. The Sharpe Ratio of 1.431 suggests that the returns are relatively high compared to the risk taken. The Max Drawdown of -0.061 indicates that the stock has experienced a moderate decline in the past. Correlation analysis with peers shows that Cipla has a moderate correlation with Sun Pharma (0.3623) and Divis Labs (0.4488), but a very low correlation with Grasim (0.0152).

**Recommendation:**

Based on the analysis, I suggest a **HOLD** recommendation for Cipla. The stock's stable performance and moderate volatility indicate that it is a relatively safe investment. The Sharpe Ratio suggests that the returns are reasonable considering the risk. However, the Max Drawdown indicates that the stock may experience some decline in the future. The correlation analysis suggests that Cipla is not heavily influenced by its peers, which could be beneficial in a diversified portfolio. Overall, I recommend holding onto Cipla for now, but keeping a close eye on its performance and adjusting the portfolio as needed.